Clin2
NCT03893188Possibly a fitRecruiting

SwissPrEPared program study for HIV-negative teens and adults

HIV Preexposure Prophylaxis

Part of Infections clinical trials.

This study looks at people who join the SwissPrEPared program and who are HIV-negative. It tests how well the program’s steps can be followed and how participants do while enrolled.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
3,000 people
Ages
16 years to 120 years
Study type
Observational

Who can take part

  • You must already be part of the SwissPrEPared program
  • You must be age 16 or older
  • You must be HIV-negative (no HIV)
  • You must be able to follow all study/program steps and instructions
  • You should be able to communicate in the required language (no major language barrier)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07510048Not yet recruiting· Phase 2
CHOOSE: PrEP for young people at risk of HIV

This study tests a program called PrEP Choice to help young people learn about and start PrEP, a daily pill that prevents HIV. It aims to see if offering choices in PrEP care makes it easier to use.

San Francisco, California
NCT06406049Recruiting
Finishing HIV prevention study

This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).

Miami, Florida
NCT07438041Not yet recruiting
Linking youth to PrEP (HIV prevention) services

This study helps connect young people aged 13–24 to PrEP, a daily pill that prevents HIV. It tests whether offering PrEP in clinics or community locations makes it easier for you to get and stay on this prevention medication.

San Francisco, California
NCT07186244Recruiting
HIV Prevention Study for People Starting or Taking PrEP

This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.

Chieti, Abruzzo
NCT06804382Not yet recruiting
Helping doctors offer HIV prevention to teens

This trial trains primary care providers at certain clinics to better offer PrEP, a daily pill that prevents HIV, to adolescents and young adults. If you are a provider at one of the listed clinics, you may be able to help improve how this prevention is delivered.

Boston, Massachusetts
NCT06746675Not yet recruiting
Healthy Families PrEP for Women at Risk for HIV

This study tests a program to help women at risk for HIV get PrEP, a medicine that prevents HIV. It focuses on women who may want to have a child or have been pregnant recently.

Mbarara

Hear when a new HIV Preexposure Prophylaxis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.